http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101388776-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2012-07-31^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101388776-B1 |
| titleOfInvention | Anti-inflammatory composition containing 2, 3-bis [(2-hydroxyethyl) thio]-1, 4- naphthoquinone |
| abstract | The present invention relates to anti-inflammatory pharmaceutical composition, food composition and cosmetic composition containing 2,3-Bis [(2-hydroxyethyl) thio] -1,4-naphthoquinone as an active ingredient. The composition of the present invention has an excellent anti-inflammatory effect by fundamentally reducing the production of TNF-α, PGE 2 , and NO, which are inflammation-related factors, from the transcription stage. In addition, it does not show cytotoxicity even when treated at a high concentration, and thus can be safely applied to medicines, foods and cosmetics. Therefore, it is expected that it can be importantly applied as an anti-inflammatory agent. |
| priorityDate | 2012-07-31^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 311 of 311.